APA (7th ed.) Citation

Tadmor, T., Melamed, G., Patalon, T., Alapi, H., & Rokach, L. (2023). Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir. Leukemia & Lymphoma, 64(5), 1054. https://doi.org/10.1080/10428194.2023.2183732

Chicago Style (17th ed.) Citation

Tadmor, Tamar, Guy Melamed, Tal Patalon, Hilel Alapi, and Lior Rokach. "Rebound of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir." Leukemia & Lymphoma 64, no. 5 (2023): 1054. https://doi.org/10.1080/10428194.2023.2183732.

MLA (9th ed.) Citation

Tadmor, Tamar, et al. "Rebound of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir." Leukemia & Lymphoma, vol. 64, no. 5, 2023, p. 1054, https://doi.org/10.1080/10428194.2023.2183732.